In fact, due to its functional significance as a co-receptor, CD4 has been clinically tried as a major target in T cell-targeted therapies for the treatment of T cell-mediated autoimmune diseases such as rheumatoid arthritis (RA). The gene discussed is CD4; the disease is rheumatoid arthritis.